Advanced search
Publication Cover
Postgraduate Medicine Volume 128, 2016 - Issue 8
Submit an article Journal homepage
4,410
Views
14
CrossRef citations to date
0
Altmetric
Clinical Focus: Cardiometabolic Conditions - Original Research

Achieve control: a pragmatic clinical trial of insulin glargine 300 U/mL versus other basal insulins in insulin-naïve patients with type 2 diabetes

Gerry OsterPolicy Analysis Inc., Brookline, MA, USACorrespondence[email protected]
View further author information
,
Sean D. SullivanUniversity of Washington, Seattle, WA, USAView further author information
,
Mehul R. DalalMillennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited., Cambridge, MA, USAView further author information
,
Mahmood R. KazemiAbbott Diabetes Care, Alameda, CA, USAView further author information
,
Maria RojeskiSanofi US Inc., Bridgewater, NJ, USAView further author information
,
Carol H. WyshamRockwood Clinic, Spokane, WA, USAView further author information
,
Jennifer SungSanofi US Inc., Bridgewater, NJ, USAView further author information
,
Bryan JohnstoneSanofi US Inc., Bridgewater, NJ, USAView further author information
,
Anna M.G. CaliSanofi, Paris, FranceView further author information
,
L.J. WeiHarvard T.H. Chan, School of Public Health, Boston, MA, USAView further author information
,
Louise TraylorSanofi US Inc., Bridgewater, NJ, USAView further author information
,
Henry AnhaltT1D Exchange, Boston, MA, USAView further author information
,
Michelle HullSanofi US Inc., Bridgewater, NJ, USAView further author information
,
John Van VleetSanofi US Inc., Bridgewater, NJ, USAView further author information
&
Luigi F. MeneghiniUniversity of Texas Southwestern Medical Center and Parkland Health & Hospital System, Dallas, TX, USAView further author information
 show all
Pages 731-739 | Received 24 Aug 2016, Accepted 23 Sep 2016, Published online: 24 Oct 2016

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Nick Freemantle, Didac Mauricio, Andrea Giaccari, Timothy Bailey, Ronan Roussel, Denise Franco, Baptiste Berthou, Valerie Pilorget, Jukka Westerbacka, Zsolt Bosnyak, Mireille Bonnemaire, Anna M. G. Cali, My-Liên Nguyên-Pascal, Alfred Penfornis, Manuel Perez-Maraver, Jochen Seufert, Sean D. Sullivan, John Wilding, Carol Wysham & Melanie Davies. (2020) Real-world outcomes of treatment with insulin glargine 300 U/mL versus standard-of-care in people with uncontrolled type 2 diabetes mellitus. Current Medical Research and Opinion 36:4, pages 571-581.
Read now
Marcus Hompesch, Dhiren K. Patel, James R. LaSalle & Geremia B. Bolli. (2019) Pharmacokinetic and pharmacodynamic differences of new generation, longer-acting basal insulins: potential implications for clinical practice in type 2 diabetes. Postgraduate Medicine 131:2, pages 117-128.
Read now

Articles from other publishers (12)

Timothy S. Bailey, Pierre Evenou, Jasvinder Gill, Paulos Berhanu, Romain Raymond, Jodi Strong & Eugene E. WrightJr.Jr.. (2021) Post Hoc Analysis Evaluating the Impact of Antihyperglycemic Background Therapies on Attainment of A1C Targets Without Hypoglycemia in the ACHIEVE Control Pragmatic, Real-Life Study. Diabetes Spectrum 34:4, pages 407-418.
Crossref
John Anderson, Luigi Meneghini, Debbie Hinnen, Jasvinder Gill, Mathieu Coudert, Pierre Evenou & Medha Munshi. (2021) Target attainment in insulin-naive patients at high risk for hypoglycemia: Results from ACHIEVE Control. Journal of Diabetes and its Complications 35:4, pages 107831.
Crossref
Robert S. Epstein & J. Russell Teagarden. 2021. Pragmatic Randomized Clinical Trials. Pragmatic Randomized Clinical Trials 21 32 .
Thomas Semlitsch, Jennifer Engler, Andrea Siebenhofer, Klaus Jeitler, Andrea Berghold & Karl Horvath. (2020) (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2020:11.
Crossref
Luigi F. Meneghini, Sean D. Sullivan, Gerry Oster, Robert Busch, Anna M. G. Cali, Arnaud Dauchy, Jasvinder Gill & Timothy S. Bailey. (2020) A pragmatic randomized clinical trial of insulin glargine 300 U/ mL vs first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 6‐month outcomes of the ACHIEVE Control study . Diabetes, Obesity and Metabolism 22:11, pages 2004-2012.
Crossref
Luigi Meneghini, Lawrence Blonde, Jasvinder Gill, Arnaud Dauchy, Andrius Bacevicius, Jodi Strong & Timothy S. Bailey. (2020) Insulin glargine 300 U/ mL versus first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 12‐month outcomes of ACHIEVE Control, a prospective, randomized, pragmatic real‐life clinical trial . Diabetes, Obesity and Metabolism 22:11, pages 1995-2003.
Crossref
Eneida Mendonca & Umberto Tachinardi. 2020. Personalized and Precision Medicine Informatics. Personalized and Precision Medicine Informatics 199 213 .
Timothy S. Bailey, Fang L. Zhou, Rishab A. Gupta, Ronald Preblick, Vineet E. Gupta, Paulos Berhanu & Lawrence Blonde. (2019) Glycaemic goal attainment and hypoglycaemia outcomes in type 2 diabetes patients initiating insulin glargine 300 units/mL or 100 units/mL: Real‐world results from the DELIVER Naïve cohort study. Diabetes, Obesity and Metabolism 21:7, pages 1596-1605.
Crossref
Lawrence Blonde, Stephen A. Brunton, Pavan Chava, Rong Zhou, Juliana Meyers, Keith L. Davis, Mehul R. Dalal & Andres DiGenio. (2019) Achievement of Target A1C <7.0% (<53 mmol/mol) by U.S. Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical Practice. Diabetes Spectrum 32:2, pages 93-103.
Crossref
Inseok Hwang, Yujin Myung & Sanghoon Park. (2018) Levator Pull-Out Suture Technique for Immediate Postoperative Correction of Eyelid Asymmetry After Ptosis Surgery in Asians. Aesthetic Plastic Surgery 43:2, pages 388-394.
Crossref
Robert Ritzel, Ronan Roussel, Andrea Giaccari, Jiten Vora, Claire Brulle-Wohlhueter & Hannele Yki-Järvinen. (2018) Better glycaemic control and less hypoglycaemia with insulin glargine 300 U/mL vs glargine 100 U/mL: 1-year patient-level meta-analysis of the EDITION clinical studies in people with type 2 diabetes. Diabetes, Obesity and Metabolism 20:3, pages 541-548.
Crossref
Ildiko LingvayJason ChaoMehul R. DalalLuigi F. Meneghini. (2017) Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in High-Risk and Low-Risk Patients with Type 2 Diabetes Stratified Using Common Clinical Performance Measures. Diabetes Technology & Therapeutics 19:5, pages 315-322.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.